169 related articles for article (PubMed ID: 6830007)
1. Immunosuppressive effects of cyclophosphamide, vincristine, and L-asparaginase in dogs.
Medleau L; Dawe DL; Calvert CA
Am J Vet Res; 1983 Feb; 44(2):176-80. PubMed ID: 6830007
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive effect of L-asparaginase. Cellular and humoral studies].
Emmerling P; Finger H
Z Immunitatsforsch Allerg Klin Immunol; 1970 Nov; 140(5):472-81. PubMed ID: 4249814
[No Abstract] [Full Text] [Related]
3. [In vivo culture studies on the effect of L-asparaginase on various phases of humoral antibody production].
Hoppe I; Jahn E
Arzneimittelforschung; 1972 Jun; 22(6):985-9. PubMed ID: 5068361
[No Abstract] [Full Text] [Related]
4. Comparison of the L-asparaginases from Escherichia coli and Erwinia carotovora as immunosuppressants.
Ashworth LA; MacLennan AP
Cancer Res; 1974 Jun; 34(6):1353-9. PubMed ID: 4596965
[No Abstract] [Full Text] [Related]
5. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
Ronghe M; Burke GA; Lowis SP; Estlin EJ
Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-asparaginase on lymphocyte surface and blastogenesis.
Fidler IJ; Montgomery PC
Cancer Res; 1972 Nov; 32(11):2400-6. PubMed ID: 5082588
[No Abstract] [Full Text] [Related]
8. Effects of cyclophosphamide on the lymphoid tissues and humoral and cellular immune responsiveness of young calves.
Corrier DE; Adams LG; Pierce KR
Am J Vet Res; 1979 Dec; 40(12):1683-9. PubMed ID: 118689
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effects of cyclophosphamide in pigs.
Mackie EJ
Am J Vet Res; 1981 Feb; 42(2):189-94. PubMed ID: 6973301
[TBL] [Abstract][Full Text] [Related]
10. [L-Asparaginase as an immunosuppresive agent].
Derezić D; Silobrcić V
Lijec Vjesn; 1974 Aug; 96(8):481-8. PubMed ID: 4461900
[No Abstract] [Full Text] [Related]
11. L-asparaginase: suppression of the immune response of mice to sheep red blood cells.
Ohno R; Harris JE; Hersh EM
Clin Exp Immunol; 1970 Aug; 7(2):221-7. PubMed ID: 4920604
[TBL] [Abstract][Full Text] [Related]
12. Suppression of immunologic function and degeneration of lymphoid organs in cyclophosphamide-treated turkeys.
Elmubarak AK; Sharma JM; Lee LF; Sanger VL
Am J Vet Res; 1981 Dec; 42(12):2122-8. PubMed ID: 6803620
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive action of L-asparaginase.
Alexander P
Proc R Soc Med; 1972 Mar; 65(3):265-6. PubMed ID: 5083314
[No Abstract] [Full Text] [Related]
14. Effects of drugs on immune responsiveness in rabbits.
van den Broek AA; Keuning FJ
Dev Biol Stand; 1977 Apr 13-15; 38():167-72. PubMed ID: 344095
[TBL] [Abstract][Full Text] [Related]
15. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of L-asparaginase and methotrexate administered at intermediate doses in dogs.
Bortnowski HB; Rosenthal RC
Am J Vet Res; 1991 Oct; 52(10):1636-8. PubMed ID: 1767984
[TBL] [Abstract][Full Text] [Related]
17. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
18. Immunological responses to L-asparaginase.
Peterson RG; Handschumacher RE; Mitchell MS
J Clin Invest; 1971 May; 50(5):1080-90. PubMed ID: 4101590
[TBL] [Abstract][Full Text] [Related]
19. Studies on the immunosuppressive activity of L-asparaginase.
Marai R; Guyonnet JC; Julou L; De Ratuld Y; Werner GH
Recent Results Cancer Res; 1970; 33():160-9. PubMed ID: 4949160
[No Abstract] [Full Text] [Related]
20. Protective immunity against Newcastle disease: the role of cell-mediated immunity.
Reynolds DL; Maraqa AD
Avian Dis; 2000; 44(1):145-54. PubMed ID: 10737655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
